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http:WHAT THIS PAPER ADDS?
This observational study combines several small AAA surveillance programmes in order to determine what the
outcomes of patients with sub-aneurysmal aortic dilatation, 25 mme29 mm diameter, are. Using time to event
analysis we determined that at 10 years of follow up 26.2% had developed an AAA of greater than 54 mm.Objectives: Currently most abdominal aortic aneurysm screening programmes discharge patients with aortic
diameter of less than 30 mm. However, sub-aneurysmal aortic dilatation (25 mme29 mm) does not represent
a normal aortic diameter. This observational study aimed to determine the outcomes of patients with screening
detected sub aneurysmal aortic dilatation.
Design and methods: Individual patient data was obtained from 8 screening programmes that had performed
long term follow up of patients with sub aneurysmal aortic dilatation. Outcome measures recorded were the
progression to true aneurysmal dilatation (aortic diameter 30 mm or greater), progression to size threshold for
surgical intervention (55 mm) and aneurysm rupture.
Results: Aortic measurements for 1696 men and women (median age 66 years at initial scan) with sub-
aneurysmal aortae were obtained, median period of follow up was 4.0 years (range 0.1e19.0 years). Following
Kaplan Meier and life table analysis 67.7% of patients with 5 complete years of surveillance reached an aortic
diameter of 30 mm or greater however 0.9% had an aortic diameter of 54 mm. A total of 26.2% of patients with
10 complete years of follow up had an AAA of greater that 54 mm.
Conclusion: Patients with sub-aneurysmal aortic dilatation are likely to progress and develop an AAA, although
few will rupture or require surgical intervention.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Abdominal aortic aneurysms (AAA) are associated with high
mortality when they rupture (RAAA). The Multi-centre
Aneurysm Screening Study (MASS) demonstrated that
screening asymptomatic males aged 65e74 reduces aneu-
rysm related mortality.1 This, and additional evidence from
other studies of AAA screening have led to the adoption of
AAA screening programmes in many countries.2,3 In most
screening programmes, a policy of regular ultrasound scan
surveillance is adopted for men with infra-renal aortic
diameters between 30 mm and 54 mm with referral for
elective aneurysm repair for those with AAAs above 54 mm
(either at detection or whilst under surveillance). Patients
with aortic diameters of less than 30 mm are usually
J.B. Wild et al. 129discharged as it is perceived that there is no risk of aortic
rupture in these patients.4
However, many authors consider aortic diameters between
25 mm and 29 mm as being not normal and there have been
reports of such patients with sub-aneurysmal aortic dilatation
progressing to develop true AAA and even rupture.5,6 Sub-
aneurysmal aortic dilatation has been reported to have
a prevalence of 2.1% in 65 year old males5 and for screening
programmes, this patient group is therefore likely to repre-
sent a similar number of patients as those detected to have
AAAs. Recent evidence indicates that patients with an aortic
diameter of between 25 mm and 29 mm have signiﬁcantly
higher rates of all cause mortality when compared to those
with an aortic diameter of less the 24 mm.7
This study aims to determine the long-term outcomes of
patients with sub-aneurysmal aortic dilatation through the
combination of individual patient level data from commu-
nity surveillance.METHODS
This article was completed in accordance with the STROBE
statement. Individual patient data from 8 community
screening and surveillance studies was obtained. Datasets
for inclusion were identiﬁed by contacting authors of
publications that had reported the outcomes of such
patients previously and via personal communication with
individuals known to have such datasets. Datasets were
included in the study if they contained serial ultrasound
measurements of aortic size in patients found to have an
infra-renal aortic diameter between 25 mm and 29 mm at
the time of screening. The time to referral for repair and/or
AAA rupture were obtained where available from each
centre. A pragmatic deﬁnition of rupture was adopted
whereby individual contributing centres reported this
outcome based upon their local policies. This may have
been from post mortem examination or admission due to
RAAA however there was no formal system of reporting
adopted.
The methodology of determining the aortic diameter was
not uniform between the centres. Measurement of aortic
diameter was always taken in the antero-posterior orien-
tation, however, some groups recorded the diameter from
the anterior outermost aortic wall to the posterior outer-
most wall (OTO) and some groups used the anterior
innermost wall to the posterior innermost wall (ITI). Since it
is known that there are discrepancies between the two
methods8,9 the method used in each contributing dataset
was recorded. The effect of method of measurement, ITI or
OTO, was subsequently analysed.
Ethical approval was not considered necessary as this was
a non interventional, retrospective observational study.
Datasets from individual centres were combined into one
single dataset for analysis using standard time-to-event
techniques without using meta-analytical statistical combi-
nation.10 Statistical analysis was performed using SPSS v18
(IBM 2010) KaplaneMeier analysis was used to estimate
time-to-event results. Cox regression analysis was used todetermine the inﬂuence of how the diameter was measured
on progression of aortic diameter and a sensitivity analysis
was conducted according to sample size of the study,
comparing larger and smaller studies.RESULTS
A total of 1696 individuals (66 female) with initial aortic
diameters between 25 mm and 29 mm with long-term
surveillance data were included in this study. These data
were obtained from 8 centres across Europe (6 UK, 1
Finland, and 1 Denmark). The characteristics of the
contributed datasets are shown in Table 1. All studies uti-
lised ultrasound to determine the diameter of the aorta.
The period of follow up varied between centres, as did
recall interval (Table 1). Data regarding RAAA and related
mortality was available in 7 of the datasets. Median period
of follow up was 4.0 years (range 0.1e19.0 years).
The ﬁrst outcome assessed was the progression of sub-
aneurysmal aortic dilatation to true aneurysmal dilatation
(diameter greater than 29 mm). A total of 1011 of the 1696
subjects (59.6%) developed true aneurysms at a mean time
of 4.7 years (95% conﬁdence interval 4.5 yearse5.0 years),
the median time was 4.0 years (range 0.1 yearse16.3 years)
(Fig. 1). At the 5 year point there were 774 aneurysms
detected and 369 patients were still under surveillance,
therefore 67.7% of patients had developed an aneurysm by
5 years, 96% by 10 years (983 aneurysms and 41 still in
surveillance). The median age at ﬁrst scan was 66 years old
(range 56 yearse71 years).
Secondly, we determined the number of patients with
sub-aneurysmal aortic dilatation who developed large
aneurysms (aortic diameter greater than 54 mm). Only 140
of the 1696 patients (8.3%) with sub-aneurysmal aortic
dilatation developed large AAA at a mean time of 13.2 years
(95% conﬁdence interval 12.6 yearse13.7 years) (Fig. 2) the
median time was 12.6 years (range 1.2 yearse19.5 years).
Of those patients who developed large AAA, 4.3% had done
so by 5 years and 47.7% by 10 years. An alternative method
of interpreting these results is that a total of 189 patients
had 10 years or more of surveillance and 67 patients had
reached 55 mm by this time, therefore 26.1% of patients
with 10 years follow-up reached the threshold for surgery.
Although a diameter of 54 mm represents the current
threshold for referral from screening for consideration of
repair, certain groups utilised a diameter of 50 mm as the
threshold for referral. Therefore analysis of the data for
patients progressing to an aortic diameter of greater than
50 mm was conducted (195 of the 1696 patients, 11.5%,
reached this diameter). The mean time for an ectatic aorta
to reach this size was 11.9 years (95% conﬁdence interval
11.4 yearse12.4 years) (Fig. 3) the median time was 11.1
years (range 0.8 yearse18.5 years). Of those patients
reaching an aortic diameter of 50 mm, 6.7% had done so by
5 years of surveillance, 60.1% by 10 years and 96.4% by 15
years.
Our ﬁnal endpoint was progression to aortic rupture.
Data was available from 7 sites (1631 patients) however as
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Table 1. The participants in the sub aneurysmal aortic dilation study.
Country and
Region
No of patients
(no. female)
Median age at
ﬁrst scan in years
Mean baseline
aortic diameter
Frequency of follow up
(Duration of programme)
Period of Follow-up
in years (Range)
Mean No. of
scans per
person
Method of
measurement
Previously published
Finland, Oulu 8 (1) 70 27.0 mm Mixed (1991e2000) 8.2 (5.1e10.5) 2.0 Outer to outer Biancari et al.11
Denmark, Viborg 127 (0) 66 26.5 mm Annual (1994e2005) 5.7 (2.7e11.0) 2.4 Outer to outer Lindholt et al.6,a
UK, Bournemouth 92 (22) 70 27.1 mm Varied (1993e2010) 4.0 (10.5e13.0) 6.3 Outer to outer Parvin12
UK, Chichester 128 (0) 65 27.0 mm Alternate years (2004e2011) 3.9 (1.9e7.4) 4.9 Inner to inner Hafez et al.13,a
UK, Gloucester 924 (0) 65 27.1 mm Varied (1990e2011) 5.5 (0.1e19.5) 6.7 Inner to inner McCarthy et al.5,a
UK, Leicester 309 (1) 66 27.2 mm Alternate Years (1996e2010) 4.8 (0.6e14.) 6.1 Outer to outer Gibbs et al.14,a
UK, Manchester 43 (16) 66 28.0 mm Annual (2001e2011) 3.5 (0.5e10.1) 3.8 Outer to outer McCollum-personal
communication
UK, Stirling 65 (26) 68 26.7 mm Alternate years (1994e2011) 4.6 (0.1e15.5) 2.5 Not stated Holdsworth-personal
communication
a Dataset has been updated from published data.
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Figure 3. Cumulative number of RAAA following entry in to
surveillance.
J.B. Wild et al. 131there was no formal system of deﬁning an aortic rupture we
believe RAAA may be under-reported. Additionally the
rupture rate will be inﬂuenced by patients under surveil-
lance being referred for surgical correction of their aneu-
rysm. Of the 14 ruptures known to have occurred the mean
time from presentation to rupture was 18.7 years (95%
conﬁdence interval 18.3 yearse19.1 years) (Fig. 3). Median
aortic diameter at presentation of the patients that went on
to rupture was 26 mm (range 25e29) and median age at
presentation was 65 years old (range 64 yearse72 years).
Survival table analysis revealed at ﬁve years 0.3% of
patients remaining under surveillance had ruptured
(2 ruptures, 711 individuals in surveillance) at 10 years
follow-up this was 3.1% (7 ruptures, 222 individuals in
surveillance). 10 RAAA patients died, 71.4% (95% CI 45.4%e
88.3%). The median age at rupture was 76 years (range 68
yearse84 years).
The use of either ITI or OTO measurement to determine
the aortic diameter is contentious; therefore we compared
the mean time from initial scan to an event based upon the
method of measurement.8,9 Two sites utilised ITI
measurement, 5 utilised OTO and one site did not specify
the method by which the aortic diameter was determined.
In terms of progression to true aneurysmal dilatation
(30 mm aortic diameter) there was little difference in
comparison of the methods of measurement, with a mean
time of 4.6 years in the ITI group and 4.7 years in the OTO
group (Table 2) and formal statistical comparison revealed
no signiﬁcant difference between the ITI and OTO groups
(hazard ratio for OTO group 0.91 (95% conﬁdence interval
0.80 to 1.04, P ¼ 0.17). The group that did not specify
method of aortic measurement had a mean time to trueTable 2. Total numbers of patients that progressed to aortic diameters
stratiﬁed by method of measuring aortic diameter. ITI ¼ Inner wall to
aortic measurement.
Method of
measurement
n Progression to 30 mm
5 years (%) 10 years (%) Mean time
30 mm (95%
ITI 1052 484 (71.0) 617 (96.4) 4.6 years (4
OTO 579 272 (64.9) 333 (75.0) 4.7 years (4
Not Speciﬁed 65 18 (42.9) 34 (85.0) 6.6 years (5aneurysmal dilatation of 6.6 years, a sizeable deviation from
the results of other groups. In terms of progression to an
aortic diameter of 55 mm, there was again little difference
in comparison of the methods of measurement, mean time
to event was 12.9 years in the ITI group, 14.6 years in the
OTO group and 13.6 years in the group that did not specify
their method of assessment (Table 2) (hazard ratio for OTO
group 1.56 (95% conﬁdence interval 0.94 to 2.60, P ¼ 0.08)
Cox Regression). Finally, when comparing the progression to
aneurysm ruptures the mean time to event was 18.9 years
in the ITI group and 16.3 years in the OTO group (hazard
ratio for OTO group 2.85 (95% conﬁdence interval 0.89 to
2.85, P ¼ 0.08) Cox Regression).
We performed a sensitivity analysis to determine
whether the results presented above were inﬂuenced by
any measures of study quality. The only robust measure
available was study size and we therefore compared the
results from the data contributed by the four studies in the
lower half of the range of study sizes (less than 100
patients) with all others. Very little difference was observed
for all outcomes between the aggregated low volume
studies and the aggregated high volume studies (Table 3).
The mean time for progression to true aneurysm aortic
diameter (30 mm) in larger studies was 4.7 years and in
smaller studies it was 5.0 years (Table 3). The mean time for
progression to large aneurysm (>54 mm) in larger studies
(127 or more patients), was 13.1 years and in smaller
studies, it was 14.6 years (Table 3). Comparison of the mean
time to aneurysm rupture was not possible as no ruptures
were reported in the groups with less than 100 patients.DISCUSSION
This study shows that the majority of patients with sub-
aneurysmal aortic dilatation progress to true aneurysmal
aortic dilatation, with almost half of these doing so within 5
years of follow-up. Furthermore, the study also shows that
within 10 years of detection, a smaller proportion
(approximately 4%) will progress to an aortic diameter that
would be considered at or above the threshold for surgical
intervention. The proportion of patients with sub-aneu-
rysmal aortic dilatation who progress to true aneurysmal
dilatation or develop large AAA is similar irrespective of the
method of ultrasound measurement used (ITI or OTO), as
demonstrated in the sensitivity analysis.
The principle strength of this study is the large combined
sample size available for analysis. The results from most of
the individual cohorts that contributed to this study haveof greater than 29 mm and greater than 54 mm by 5 and 10 years,
inner wall aortic measurement, OTO ¼ Outer wall to outer wall
Progression to 54 mm
to
CI)
5 years (%) 10 years (%) Mean time to 55 mm
(95% CI)
.3e4.8) 4 (0.95) 54 (28.3) 12.9 years (12.3e13.5)
.3e5.0) 2 (1.1)) 6 (15.7) 14.6 years (12.6e16.7)
.4e7.7) 1 (5.6) 2 (25.0) 13.6 years (11.9e15.3)
Table 3. Total numbers of patients that progressed to aortic diameters of greater than 29 mm and greater than 54 mm by 5 and 10 years,
stratiﬁed by cohort size. Large cohorts were deﬁned as the top 4 cohorts contributing to the study in terms of size (127, 128, 309 and 924
patients) with all other cohorts being classiﬁed as small (8, 43, 65 and 92 patients).
Cohort
size
n Progression to 30 mm Progression to 55 mm
5 years (%) 10 years (%) Mean time to
30 mm (95% CI)
5 years (%) 10 years (%) Mean time to
55 mm (95% CI)
Large 1487 687 (68.6) 859 (96.5) 4.7 years (4.5e4.9) 6 (1.0) 60 (25.6) 13.1 (12.5e13.7)
Small 209 87 (61.3) 124 (92.5) 5.0 years (4.4e5.6) 1 (1.9) 7 (31.8) 14.6 (12.3e16.8)
132 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 2 February/2013been published in part previously5,6,11e14 with a variety of
conclusions drawn regarding the beneﬁt of continued
surveillance in patients with sub-aneurysmal aortic dilata-
tion. Unsurprisingly, these studies have all shown similar
ﬁndings to this combined analysis. However, similar results
have been observed in small datasets that were not
included in this analysis.15,16 The sensitivity analysis pre-
sented demonstrates that when considering the results
from the group of patients drawn from smaller cohorts,
similar results are seen when compared to the results from
the larger cohorts. This, taken together with the fact that
other small studies have found similar results, suggests that
the analysis of small cohorts remains valuable. This may be
particularly useful for the determination of covariate effects
on the progression of sub-aneurysmal dilatation providing
sample sizes allow at least 100 patients in each covariate
sub-group. Additionally as our analysis utilises time to event
data we are able to allow for patients who fail to participate
in full screening without adversely effecting our data. The
follow-up regime varied greatly between the programmes
that contributed data to this analysis. Annual rescanning
was completed in Viborg, Manchester and Gloucester,
alternate yearly scans were offered in Chichester, Stirling
and Leicester, 3e6 monthly scanning was conducted in Oulu
whilst a varied rescan interval was performed in Bourne-
mouth. As the landmarks used in aneurysm measurement
also varied between study centres, we have examined this
effect within our sensitivity analysis. It has been previously
demonstrated that ITI measurement is superior to OTO in
terms of reproducibility,8 however some centres also use
a method of measuring the aneurysm leading edge to
leading edge, as these structures are more clearly deﬁned in
ultrasound imaging.3 As the aortic wall may contribute up
to 4 mm of the total diameter it is important to understand
the potentially wide variation in an ITI and OTO measure-
ment, despite the deﬁnition for a sub-aneurysmal aortae
being the same for both. Therefore the use of these 2 forms
of measurement is a limitation of this study, which we have
attempted to correct for. Sensitivity analysis comparing ITI
and OTO methodology revealed no signiﬁcant difference in
terms of size progression, ensuring that combining these
methods of surveillance is reliable. None of these centres
included inter and intra-observer variability analyses. It is
also unknown how many patients were lost to follow up
due to either a change in location, mortality, or termination
of their surveillance either due to a non-progressing aortic
diameter or co-morbidities.
To accurately evaluate the impact of possessing a sub-
aneurysmal aorta, comparison of this data to a cohort ofpatients with normal aortic diameters would be ideal.
Although this has not been undertaken within this study,
the risk of future AAA development requiring intervention
beyond this point is negligible, with Crow et al.17 observing
that 1.8% of patients developed an aneurysm diameter
>30 mm after 12 years of follow up.
This study was unable to assess the effect of environ-
mental or patient-related factors on the progression of sub-
aneurysmal aortic dilatation to true aneurysmal dilatation
because of a lack of consistently deﬁned covariate data in
the contributing cohorts. The main effect of this deﬁciency
is that limited clinical recommendations can be made on
the basis of this study alone. However, large datasets
examining the effect of covariate data on the progression of
small AAA are becoming available18 and since the majority
of patients with sub-aneurysmal dilatation progress to true
aneurysmal dilatation, clinical recommendations for the
management of patients with small AAA are also likely to be
applicable to patients with sub-aneurysmal dilatation.
Similarly, additional outcomes such as the proportion of
patients referred for surgery and the outcomes of surgery in
these patients could not be assessed because of a lack of
robust data in the contributing cohorts but these are again,
likely to be similar to those observed in cohorts of patients
with small AAA.
The known rate of ruptured AAA in this study was low
(0.9% over a median period of follow up of 4.0 years). Since
each individual in this study was not followed up clinically,
nor were causes of death established for every individual in
the study, we cannot be certain that this is the true rate of
rupture. In addition, all subjects in this study were in
surveillance programmes, and many of those who would
have ruptured without surveillance will have been referred
for surgical repair thus preventing rupture (or in cases
where patients were turned down for surgical repair,
further surveillance terminated). It is likely that the true
rupture rate of patients with sub-aneurysmal aortic dilata-
tion is higher than that observed here but to what extent
cannot be determined. As the length of time from initial
scan to rupture is 18.7 years the time interval prior to
rescanning should clearly be less than this, however as the
true rate of rupture outside of surveillance in this subgroup
of patients is not known, the exact time of rescanning
cannot be determined. In addition, two patients ruptured
following less than 5 years follow up, which is the time
interval for rescanning sub-aneurysmal aortae in several
Swedish counties.
In the UK 300,000 men per year are offered aneurysm
screening, with 2.1% of these patients measuring 25e29 mm.
J.B. Wild et al. 133If routine surveillance for these patients is offered, as in the
Swedish model at 5 years, this would represent a modest
increase in the number of patients attending for rescreening
(6300 patients per year), and 59.6%of these patientsmay then
enter long term annual surveillance (3755 patients per year).
Although an analysis of cost effectiveness is outside the
remit of this study, as the Swedish Aneurysm Surveillance
programme is known to be cost effective, and is the only
programme to include sub-aneurysmal aortae at present, it is
likely that including sub-aneurysmal aortae will be cost
effective.
The outcomes from this study raise the question of
rescanning patients with sub-aneurysmal aortae. Previous
studies have advocated between 2 and 5 years [Hafez 2008,
McCarthy 2003] and the proposal from several of the Swedish
Counties surveillance programmes is also for a ﬁve year
rescan of sub-aneurysma; aortae. If it is interpreted that the
goal of screening is to prevent rupture then from the data in
our possession, the rescreening interval required would need
to be 5 years as it is at this time point which 10 of the 14 (the
remaining 4 did not have a ﬁfth year scans, 2 had died and 2
had a tenth year rescan) patients who suffered RAAA had
reached a >30 mm aortic diameter and we propose should
enter screening. However, recent data from the long term
analysis of mortality in patients with sub-aneurysmal aortae
has demonstrated a signiﬁcant level of all-cause mortality
(10.3% at a median of 7 years). This calls the rationale of
surveillance of these patients in to question, although the
data for this paper was collected in the early 21st century and
improvement in the management of cardiovascular disorders
and malignancies is likely to reduce this mortality. This makes
the presence of a small aneurysmmore signiﬁcant clinically in
the modern era.7 In addition, entering these patients into the
aneurysm screening programme will have a cost impact, the
extent of which remains unknown. As such, the authors
believe that a cost-effective analysis should be undertaken to
determine the cost implications for screening sub-aneu-
rysmal aortae prior to any implementation.
An additional limitation is that few patients from our
original cohort completed 10 years of surveillance, roughly
25% of patients were still in follow up at this point and this
must be taken in to account when evaluating the data.
The ﬁndings in this study are made more pertinent by
recent evidence that AAA is an ageing disease.19,20 The
average age for presentation of clinically relevant aneurysm
has increased19 and in England, non-ruptured AAA presen-
tation has shifted upwards by approximately 2 years.2 This
is thought to be due to a healthier lifestyle (reduction in
smoking) which may serve to delay the onset of the disease
in genetically predisposed individuals. Reduced rates of
smoking, one third of previously observed rates, have been
reported, with an etiological fraction over 70% for
smokers.3 This changing epidemiology of AAA indicates that
a signiﬁcant proportion of patients who would otherwise
have been detected as true aneurysms by AAA screening
programmes would now fall into the sub-aneurysmal aortic
dilation group. A policy of surveillance for this group of
patients to prevent aneurysm related mortality would seemeven more important should the current trends in AAA
epidemiology continue. In addition the general tendency for
individuals to live longer will likely lead to an increased
proportion of sub-aneurysmal aortae progressing to
a diameter that would be clinically relevant. Additionally
patients entered in to surveillance are likely to beneﬁt from
advice regarding cardiovascular health, as these patients are
likely to possess several risk factors for heart disease.21
CONCLUSION
This study suggests that the majority of screening detected
sub-aneurysmal aortae will progress to become fully
aneurysmal. In the absence of sufﬁcient natural history
data, existing evidence based protocols for small AAA
surveillance should be applied to these individuals. There is
a need to deﬁne to role of ongoing screening in this group
of patients and more studies are required, determining the
effects of medical comorbidities on the rate of aortic
expansion and rates of rupture.
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